Adjuvant Chemotherapy with Doxorubicin and Cyclophosphamide in Women with Rapidly Proliferating Node-Negative Breast Cancer
β Scribed by Stephen E. Jones; Gary Clark; Sherry Koleszar; Gaby Ethington; Robert Mennel; Steven Paulson; Barry Brooks; Ronald Kerr; Claude Denham; Michael Savin; Joanne Blum; Robert Kirby; Marvin Stone; John Pippen; Timothy George; Douglas Orr; Sally Knox; Michael Grant; George Peters; Daniel Savino; Charles Rietz
- Book ID
- 119934611
- Publisher
- CIG Media Group, LP.
- Year
- 2002
- Tongue
- English
- Weight
- 116 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1526-8209
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Several large, randomized trials established the benefits of adjuvant trastuzumab with chemotherapy. However, the benefit for women with small, nodeβnegative HER2βpositive (HER2+) disease is unknown, as these patients were largely excluded from these trials. Therefore, a